207 related articles for article (PubMed ID: 19548455)
1. [Polymorphism of osteoprotegerin gene and osteoporosis in postmenopausal women].
Seremak-Mrozikiewicz A; Tatuśko J; Drews K; Barlik M; Krajewski P; Spaczyński M; Mrozikiewicz PM
Ginekol Pol; 2009 May; 80(5):354-60. PubMed ID: 19548455
[TBL] [Abstract][Full Text] [Related]
2. Polymorphisms of OPG and their relation to the mineral density of bones in pre- and postmenopausal women.
Boroń D; Kotrych D; Bartkowiak-Wieczorek J; Uzar I; Bogacz A; Kamiński A
Int Immunopharmacol; 2015 Sep; 28(1):477-86. PubMed ID: 26202809
[TBL] [Abstract][Full Text] [Related]
3. Association between osteoprotegerin (OPG), receptor activator of nuclear factor-kappaB (RANK), and RANK ligand (RANKL) gene polymorphisms and circulating OPG, soluble RANKL levels, and bone mineral density in Korean postmenopausal women.
Kim JG; Kim JH; Kim JY; Ku SY; Jee BC; Suh CS; Kim SH; Choi YM
Menopause; 2007; 14(5):913-8. PubMed ID: 17667143
[TBL] [Abstract][Full Text] [Related]
4. The RANKL/RANK/OPG signal trail: significance of genetic polymorphisms in the etiology of postmenopausal osteoporosis.
Wolski H; Drews K; Bogacz A; Kamiński A; Barlik M; Bartkowiak-Wieczorek J; Klejewski A; Ożarowski M; Majchrzycki M; Seremak-Mrozikiewicz A
Ginekol Pol; 2016; 87(5):347-52. PubMed ID: 27304650
[TBL] [Abstract][Full Text] [Related]
5. The relationship between osteoprotegerin gene polymorphisms and bone mineral density in Chinese postmenopausal women.
Wang Q; Chen Z; Huang Y; Li Q; Zhu L; Cai X; He G; Xie Y; Liu Q
Int Immunopharmacol; 2013 Oct; 17(2):404-7. PubMed ID: 23856613
[TBL] [Abstract][Full Text] [Related]
6. The influence of osteoprotegerin genetic polymorphisms on bone mineral density and osteoporosis in Chinese postmenopausal women.
Sun T; Chen M; Lin X; Yu R; Zhao Y; Wang J
Int Immunopharmacol; 2014 Sep; 22(1):200-3. PubMed ID: 24975835
[TBL] [Abstract][Full Text] [Related]
7. RANKL and OPG gene polymorphisms: associations with vertebral fractures and bone mineral density in premenopausal systemic lupus erythematosus.
Bonfá AC; Seguro LP; Caparbo V; Bonfá E; Pereira RM
Osteoporos Int; 2015 May; 26(5):1563-71. PubMed ID: 25609157
[TBL] [Abstract][Full Text] [Related]
8. Association of the osteoprotegerin gene polymorphisms with bone mineral density in postmenopausal women.
Arko B; Prezelj J; Kocijancic A; Komel R; Marc J
Maturitas; 2005 Jul; 51(3):270-9. PubMed ID: 15978970
[TBL] [Abstract][Full Text] [Related]
9. The influence of Lys3Asn polymorphism in the osteoprotegerin gene on bone mineral density in Chinese postmenopausal women.
Zhao HY; Liu JM; Ning G; Zhao YJ; Zhang LZ; Sun LH; Xu MY; Uitterlinden AG; Chen JL
Osteoporos Int; 2005 Dec; 16(12):1519-24. PubMed ID: 15782282
[TBL] [Abstract][Full Text] [Related]
10. Association of genetic polymorphisms of RANK, RANKL and OPG with bone mineral density in Chinese peri- and postmenopausal women.
Shang M; Lin L; Cui H
Clin Biochem; 2013 Oct; 46(15):1493-501. PubMed ID: 23531404
[TBL] [Abstract][Full Text] [Related]
11. OPG, RANKL, and RANK gene polymorphisms and the bone mineral density response to alendronate therapy in postmenopausal Chinese women with osteoporosis or osteopenia.
Zheng H; Wang C; He JW; Fu WZ; Zhang ZL
Pharmacogenet Genomics; 2016 Jan; 26(1):12-9. PubMed ID: 26426211
[TBL] [Abstract][Full Text] [Related]
12. TNFRSF11B gene polymorphisms 1181G > C and 245T > G as well as haplotype CT influence bone mineral density in postmenopausal women.
Mencej-Bedrač S; Preželj J; Marc J
Maturitas; 2011 Jul; 69(3):263-7. PubMed ID: 21411255
[TBL] [Abstract][Full Text] [Related]
13. Association analyses of osteoprotegerin gene polymorphisms with bone mineral density in Chinese postmenopausal women.
Zhang F; He C; Chen G; Li F; Gao H
Med Oncol; 2013 Mar; 30(1):389. PubMed ID: 23335067
[TBL] [Abstract][Full Text] [Related]
14. The effects of osteoprotegerin (OPG) gene polymorphism in patients with ischaemic heart disease on the morphology of coronary arteries and bone mineral density.
Celczyńska Bajew L; Horst Sikorska W; Bychowiec B; Wykrętowicz A; Wesoły J; Michalak M
Kardiol Pol; 2011; 69(6):573-8. PubMed ID: 21678294
[TBL] [Abstract][Full Text] [Related]
15. [Genetic polymorphism of the calcitonin receptor gene and bone mineral density in Polish population of postmenopausal women].
Drews K; Seremak-Mrozikiewicz A; Bartkowiak-Wieczorek J; Pieńkowski W; Dubiel M; Mrozikiewicz PM
Ginekol Pol; 2005 Aug; 76(8):612-8. PubMed ID: 16363366
[TBL] [Abstract][Full Text] [Related]
16. Genetic polymorphisms of OPG, RANK, and ESR1 and bone mineral density in Korean postmenopausal women.
Choi JY; Shin A; Park SK; Chung HW; Cho SI; Shin CS; Kim H; Lee KM; Lee KH; Kang C; Cho DY; Kang D
Calcif Tissue Int; 2005 Sep; 77(3):152-9. PubMed ID: 16151677
[TBL] [Abstract][Full Text] [Related]
17. [Effect of osteoprotegerin gene polymorphism on bone mass in postmenopausal women].
Cheng Q; Zhu HM; Miao YX; Zhu XY; Chen XP; Zhang XM
Zhonghua Yi Xue Za Zhi; 2004 Feb; 84(4):274-7. PubMed ID: 15059506
[TBL] [Abstract][Full Text] [Related]
18. The relationship between the g.27450A>T genetic variant of OPG gene and osteoporosis in Chinese postmenopausal women.
Lin H; Zhang G; Chen X; Wu X; Wu C; Ca H; Hu Z
Int Immunopharmacol; 2014 Aug; 21(2):464-7. PubMed ID: 24867796
[TBL] [Abstract][Full Text] [Related]
19. Single-nucleotide polymorphism of the osteoprotegerin gene and its association with bone mineral density in Chinese postmenopausal women.
Feng G; Meng L; Wang H; Lu Y; Jia J; Zhang Y; Zhang H; Zhang B
J Pediatr Endocrinol Metab; 2012; 25(11-12):1141-4. PubMed ID: 23329761
[TBL] [Abstract][Full Text] [Related]
20. Association of the 163A/G and 1181G/C osteoprotegerin polymorphism with bone mineral density.
García-Unzueta MT; Riancho JA; Zarrabeitia MT; Sañudo C; Berja A; Valero C; Pesquera C; Paule B; González-Macías J; Amado JA
Horm Metab Res; 2008 Mar; 40(3):219-24. PubMed ID: 18348083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]